Surgery creates a unique medical situation for people taking GLP-1 medications like tirzepatide, since these drugs affect appetite, fluid intake, and gastric emptying
pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures
It does not appear to affect insulin or glucose levels adversely, distinguishing it from other hormone-based therapies
It is used for both diabetes management and weight loss
Mild symptoms include soreness around the injection site, headache, body aches and a mild fever
Most blood pressure reductions with semaglutide are modest (25 mmHg average), and problems typically emerge only when antihypertensive dosing was already aggressive or multiple medications were excessive for the patient's baseline weight and cardiovascular status